Clobutinol
Clobutinol is a non-opioid cough suppressant or antitussive drug which was previously widely available worldwide. It was discovered and brought to market by Boehringer Ingelheim in 1961. However, it was withdrawn from the market worldwide in 2007-2008 due to concerns about cardiac toxicity.
Pharmacology[edit]
Clobutinol works by suppressing the cough reflex in the central nervous system. It is a non-opioid antitussive, meaning it does not have the risk of dependency associated with opioid cough suppressants. However, it has been associated with potentially serious cardiac side effects, including QT interval prolongation, which can lead to life-threatening arrhythmias.
History[edit]
Clobutinol was first discovered and brought to market by the German pharmaceutical company Boehringer Ingelheim in 1961. It was widely used for many years as a cough suppressant. However, in 2007, it was withdrawn from the market in Germany due to concerns about cardiac toxicity. This was followed by a worldwide withdrawal in 2008.
Side Effects[edit]
The most common side effects of clobutinol include drowsiness, dizziness, and nausea. However, the most serious side effect is QT interval prolongation, which can lead to life-threatening arrhythmias. This side effect led to the withdrawal of clobutinol from the market worldwide.
Withdrawal from Market[edit]
In 2007, clobutinol was withdrawn from the market in Germany after a review of safety data showed an increased risk of QT interval prolongation and arrhythmias. This was followed by a worldwide withdrawal in 2008. The withdrawal was voluntary and was carried out by the manufacturers.
See Also[edit]
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
